Results 81 to 90 of about 277,876 (250)

Thyroid-stimulating immunoglobulins as measured in a reporter bioassay are not detected in patients with Hashimoto’s thyroiditis and ophthalmopathy or isolated upper eyelid retraction

Clinical Ophthalmology, 2014
Jack R Wall,1 Hooshang Lahooti,1 Ilhem El Kochairi,1 Simon D Lytton,2 Bernard Champion1 1Department of Medicine, the University of Sydney, Penrith, NSW, Australia; 2SeraDiaLogistics, Munich, Germany Abstract: Although ophthalmopathy is mainly ...
Wall JR, Lahooti H, El Kochairi I, Lytton SD, Champion B   +4 more
doaj  

Cigarette Smoke Extract-Induced Oxidative Stress and Fibrosis-Related Genes Expression in Orbital Fibroblasts from Patients with Graves' Ophthalmopathy

Oxidative Medicine and Cellular Longevity, 2016
Cigarette smoking is the most important risk factor for the development or deterioration of Graves' ophthalmopathy. Smoke-induced increased generation of reactive oxygen species may be involved. However, it remains to be clarified how orbital fibroblasts
H. Kau, Shi-Bei Wu, Chieh-Chih Tsai, C. J. Liu, Yau-Huei Wei   +4 more
semanticscholar   +1 more source

Management of patients with endocrine ophthalmopathy and Graves' disease: results of an endocrinologist and ophthalmologist survey in Russia

Медицинский совет, 2015
Endocrine ophthalmopathy is a chronic autoimmune disease of the orbit which can cause loss of vision. It is a multidisciplinary problem involving specialists from different areas.

doaj   +1 more source

Thyroid antibody-negative euthyroid Graves’ ophthalmopathy

Endocrinology, Diabetes & Metabolism Case Reports, 2016
Summary TSH receptor antibodies (TRAbs) are the pathological hallmark of Graves’ disease, present in nearly all patients with the disease. Euthyroid Graves’ ophthalmopathy (EGO) is a well-recognized clinical entity, but its occurrence in patients with ...
A. Tabasum, I. Khan, P. Taylor, G. Das, O. Okosieme   +4 more
semanticscholar   +1 more source

Radiation therapy for Graves' ophthalmopathy: a systematic review and meta-analysis of randomized controlled trials [PDF]

, 2012
Gustavo Arruda Viani, André Campiolo Boin, Lígia Issa De Fendi, Ellen Carrara Fonseca, Eduardo Jose Stefano, Jayter Silva Paula   +5 more
openalex   +1 more source

MODERN APPROACHES TO THE THERAPY OF ENDOCRINE OPHTHALMOPATHY

Žurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta, 2019
Background: The number of patients with thyroid disease is increasing due to people suffering from Graves' disease, which is often accompanied by endocrine autoimmune ophthalmopathy.
Nikonova L. V., Tishkovskiy S. V., Hadomskaya V. I., Davydchyk E. V., Doroshkevich I. P.   +4 more
doaj   +1 more source

Predictive Factors of Development of Graves' Ophthalmopathy for Patients with Juvenile Graves' Disease

International Journal of Endocrinology, 2016
Background. Due to low incidence of Graves' ophthalmopathy (GO) among children, the manifestation is poorly analyzed, posing a risk to late identification of insidious disease. Purposes.
D. Jarusaitiene, R. Verkauskienė, V. Jašinskas, J. Jankauskiene   +3 more
semanticscholar   +1 more source

Persistent hyperthyroidism and de novo Graves’ ophthalmopathy after total thyroidectomy

Endocrinology, Diabetes & Metabolism Case Reports, 2017
We report a patient with Graves’ disease who remained persistently hyperthyroid after a total thyroidectomy and also developed de novo Graves’ ophthalmopathy 5  months after surgery.
Wei Lin Tay, Wann Jia Loh, Lianne Ai Ling Lee, Chiaw Ling Chng   +3 more
doaj   +1 more source

The influence of hepatitis C infection and interferon-α therapy on thyrotropin blocking and stimulating autoantibodies in Graves' ophthalmopathy: a case report [PDF]

, 2009
Huy Tran, Glenn Reeves
openalex   +1 more source

Evaluation of changes in choroidal thickness after implantable collamer lens surgery in high myopia patients with graves’ Ophthalmopathy (inactive phase) [PDF]

, 2020
Fanglin He, Yan Liu, Renbing Jia, Jing Zhang   +3 more
openalex   +1 more source